GlobeNewswire 25/02/2019 Roche enters into definitive merger agreement to acquire Spark Therapeutics
GlobeNewswire 19/02/2019 FDA grants Priority Review to Roche's personalised medicine entrectinib
GlobeNewswire 19/02/2019 FDA grants Priority Review to Roche's polatuzumab vedotin in previously treated aggressive lymphoma
GlobeNewswire 07/02/2019 Global Genetic Testing Market Outlook 2017-2026 - Drivers, Constraints, Opportunities, Threats, Chal...
GlobeNewswire 06/02/2019 Roche joins the World Federation of Hemophilia Humanitarian Aid Program
GlobeNewswire 05/02/2019 Roche submits supplemental biologics license application to US FDA for Kadcyla for adjuvant treatmen...
GlobeNewswire 01/02/2019 CHMP recommends EU approval of Roche's Hemlibra for people with severe haemophilia A without factor ...
GlobeNewswire 01/02/2019 CHMP recommends EU approval of Roche's Tecentriq in combination with Avastin and chemotherapy as an ...
GlobeNewswire 31/01/2019 Roche reports very strong results in 2018
GlobeNewswire 30/01/2019 Roche to discontinue Phase III CREAD 1 and 2 clinical studies of crenezumab in early Alzheimer's dis...
GlobeNewswire 17/01/2019 FDA accepts Roche's supplemental biologics license application for Tecentriq plus chemotherapy (Abra...
GlobeNewswire 14/01/2019 Personal Internet of Things (IoT) and Connected Devices Markets, 2018-2023: Wearables and IoT Device...
GlobeNewswire 17/12/2018 PRIME designation granted by European Medicines Agency for Roche's risdiplam for treatment of spinal...
GlobeNewswire 10/12/2018 New member proposed for election to Roche Board of Directors
GlobeNewswire 10/12/2018 Changes to the Roche Corporate Executive Committee
GlobeNewswire 07/12/2018 FDA approves Roche's Tecentriq in combination with Avastin and chemotherapy for the initial treatmen...
GlobeNewswire 05/12/2018 Roche's Kadcyla cut the risk of disease recurring by half compared to Herceptin in people with HER2-...
GlobeNewswire 05/12/2018 FDA grants priority review to Roche's Tecentriq in combination with chemotherapy for the initial tre...
GlobeNewswire 04/12/2018 New Venclexta/Venclyxto data demonstrate deep responses in two of the most common types of leukaemia
GlobeNewswire 03/12/2018 Roche's Hemlibra provided sustained bleed control in the largest pivotal study to date of children w...
GlobeNewswire 03/12/2018 Longer-term follow-up data demonstrate sustained benefit of polatuzumab vedotin-based treatment in r...
GlobeNewswire 26/11/2018 Global Spinal Muscular Atrophy Market Forecast 2017-2026: Increasing Funding for Research & Developm...
GlobeNewswire 21/11/2018 Roche announces FDA grants Venclexta accelerated approval for people with newly-diagnosed acute myel...
TeleTrader 20/11/2018 Fitch cuts Novartis to AA- for 'acquisitive strategy'
GlobeNewswire 13/11/2018 FDA grants priority review to Roche's Tecentriq in combination with Abraxane for the initial treatme...